In the latest trading session,, 48.83 million Novavax, Inc (NASDAQ:NVAX) shares changed hands as the company’s beta touched 2.75. With the company’s most recent per share price at $7.52 changing hands around $0.79 or 11.73% at last look, the market valuation stands at $1.22B. NVAX’s current price is a discount, trading about -217.29% off its 52-week high of $23.86. The share price had its 52-week low at $5.01, which suggests the last value was 33.38% up since then.
Analysts gave the Novavax, Inc (NVAX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.14. If we narrow down to specifics, the data shows that 0 out of 16 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended NVAX as a Hold, 10 felt it is a Buy and 0 rated the stock as Underweight.
Novavax, Inc (NASDAQ:NVAX) trade information
Instantly NVAX is in green as seen in intraday trades today. With action 18.61%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -6.47%, with the 5-day performance at 18.61% in the green. However, in the 30-day time frame, Novavax, Inc (NASDAQ:NVAX) is 25.33% up.
The consensus price target for the stock as assigned by Wall Street analysts is 22, meaning bulls need an upside of 65.82% from its recent market value. According to analyst projections, NVAX’s forecast low is 14 with 174 as the target high. To hit the forecast high, the stock’s price needs a -2213.83% plunge from its current level, while the stock would need to soar -86.17% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 25.88%. The 2025 estimates are for Novavax, Inc earnings to increase by 258.75%, but the outlook for the next 5-year period is at 67.93% per year.
NVAX Dividends
Novavax, Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.984% or 11.85 million shares worth $149.98 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 4.79 shares estimated at $37.22 million under it, the former controlled 2.96% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.53% of the shares, roughly 4.09 shares worth around $31.83 million.
